BioCentury
ARTICLE | Company News

Management tracks: Adverum, Evolus

May 7, 2018 10:28 PM UTC

Adverum Biotechnologies Inc. (NASDAQ:ADVM) said President and CEO Amber Salzman has stepped down. CFO and SVP Leone Patterson is acting as interim president and CEO while the gene therapy company searches for a successor. Additionally, Athena Countouriotis resigned as Adverum's CMO, effective May 11, and VP of Clinical Development Linda Neuman will serve as interim CMO.

Dermatology company Evolus Inc. (NASDAQ:EOLS) said President and CEO Murthy Simhambhatla has left the company. The company hired David Moatazedi, who was SVP of medical aesthetics at Allergan plc (NYSE:AGN), to succeed him as president and CEO...